MDT logo

Medtronic (MDT)

Profile

Full Name

Medtronic plc

Ticker Symbol

MDT

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

Ireland

IPO

May 2, 1973

Indexes

S&P 500

Website

http://www.medtronic.com

Employees

95000

Key Details

Price

$82.93(-2.76%)

Market cap

$106.36B(Mega cap)

Last Dividend

$0.70

TTM Dividend yield

3.38%

Annual revenue

$32.36B(+3.64% YoY)

Annual EPS

$2.76(-2.13% YoY)

PE ratio

25.21

Next earnings date

May 21, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$82.93
MDT price is $82.93

30-Day Relative Volume

0.81
MDT 30-day relative volume is 0.81

Price Performance

Price Today change

-2.76%
MDT price is down -2.76% today

Price YTD change

+3.82%
MDT price is up +3.82% since January 1st

Price 1-year change

+0.73%
MDT price is up +0.73% year-on-year

Price 3-year change

-26.26%
MDT price is down -26.26% over the past 3 years

Price Range

Price All-time high

$135.89
MDT price is currently -38.97% below its historical high of $135.89

Price 3-year low

$68.84
MDT price is currently +20.47% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$106.36B
MDT market capitalization is $106.36 billion

Market cap 3-year change

-29.51%
MDT market capitalization is down -29.51% over the past 3 years

Market cap All-time high

$181.91B
MDT market capitalization is currently -41.53% below its historical high of $181.91 billion

Market cap sector rank

98.44%
MDT market capitalization is higher than 98.44% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-3.41%
MDT shares outstanding is down -3.41% year-on-year

Shares Outstanding 3-Year Change

-4.4%
MDT shares outstanding is down -4.4% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.37
MDT beta is 0.37

200-day SMA

$86.46
MDT price is currently -4.08% below its 200-day simple moving average

50-day SMA

$90.31
MDT price is currently -8.17% below its 50-day simple moving average

RSI

41.18
MDT 14-day relative strength index is 41.18

Volume

0.81
MDT 30-day relative volume is 0.81

ATR

$3.26
MDT average true range is $3.26

10-day Historical Volatility

42.46%
MDT 10-day historical volatility is 42.46%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.70
MDT last dividend was $0.70 per share, with an ex-dividend date of March 28, 2025

Next Dividend

-
MDT next dividend has not yet been announced

Dividend per share

Dividend per share

$2.76
MDT annual dividend per share is $2.76

Dividend per share Sector Rank

80.23%
MDT annual dividend per share is higher than 80.23% of companies in Healthcare sector

Dividend per share 1-Year Change

+1.47%
MDT annual dividend per share is up +1.47% year-on-year

Dividend per share 3-Year Change

+18.97%
MDT annual dividend per share is up +18.97% over the past 3 years

Dividend yield

Dividend yield

3.33%
MDT annual dividend yield is 3.33%

Dividend yield Sector Rank

65.88%
MDT annual dividend yield is higher than 65.88% of companies in Healthcare sector

Other

Payout ratio

99.73%
MDT annual payout ratio is 99.73%

Dividends paid

$3.67B
MDT annual dividends paid is $3.67 billion

Free cash flow

$5.20B
MDT annual free cash flow is $5.20 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$32.36B
MDT annual revenue is $32.36 billion

Revenue Analysts estimate

$33.50B
MDT annual revenue is currently -3.39% lower than the consensus analysts' forecast

Revenue 1-year change

+3.64%
MDT annual revenue is up +3.64% year-on-year

Revenue Sector rank

97.09%
MDT annual revenue is higher than 97.09% of companies in Healthcare sector

EPS

EPS

$2.76
MDT annual earnings per share is $2.76

EPS Analysts estimate

$5.45
MDT annual earnings per share is currently -49.40% lower than the consensus analysts' forecast

EPS 1-year change

-2.13%
MDT annual earnings per share is down -2.13% year-on-year

EPS Sector rank

93.56%
MDT annual earnings per share is higher than 93.56% of companies in Healthcare sector

Profit

Gross profit

$21.15B
MDT annual gross profit is $21.15 billion

Gross margin

65.34%
MDT annual gross profit margin is 65.34%

Operating profit

$5.52B
MDT annual operating income is $5.52 billion

Operating margin

17.06%
MDT annual operating profit margin is 17.06%

Net income

$3.68B
MDT annual net profit is $3.68 billion

Net margin

11.36%
MDT annual net profit margin is 11.36%

Expenses

Total expenses

$26.84B
MDT annual total expenses is $26.84 billion

Operating expenses

$15.63B
MDT annual total operating expenses is $15.63 billion

Cost of goods sold

$11.22B
MDT annual cost of goods sold is $11.22 billion

Selling, general & administrative expenses

$10.74B
MDT annual SGA is $10.74 billion

Depreciation and amortization

$2.65B
MDT annual depreciation & amortization is $2.65 billion

Interest expense

$719.00M
MDT annual interest expense is $719.00 million

Income tax

$1.13B
MDT annual income tax is $1.13 billion

EBIT & EBITDA

EBIT

$5.56B
MDT annual earnings before interest & taxes is $5.56 billion

EBITDA

$8.20B
MDT annual EBITDA is $8.20 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$89.98B
MDT annual total assets is $89.98 billion

Non current assets

$68.05B
MDT annual long term assets is $68.05 billion

Current assets

$21.93B
MDT annual total current assets is $21.93 billion

Cash and cash equivalents

$1.28B
MDT annual cash & cash equivalents is $1.28 billion

Accounts receivable

$6.13B
MDT annual accounts receivable is $6.13 billion

Inventory

$5.22B
MDT annual inventory is $5.22 billion

Liabilities

Total liabilities

$39.56B
MDT annual total liabilities is $39.56 billion

Long term liabilities

$28.77B
MDT annual total long term liabilities is $28.77 billion

Current liabilities

$10.79B
MDT annual total current liabilities is $10.79 billion

Accounts payable

$2.41B
MDT annual accounts payable is $2.41 billion

Debt

Total debt

$25.02B
MDT annual total debt is $25.02 billion

Total debt 1-year change

+2.71%
MDT annual total debt is up +2.71% year-on-year

Long term debt

$23.93B
MDT annual long term debt is $23.93 billion

Short term debt

$1.09B
MDT annual short term debt is $1.09 billion

Equity & Capital

Shareholders equity

$50.21B
MDT annual stockholders equity is $50.21 billion

Book value

$50.21B
MDT annual book value is $50.21 billion

Retained earnings

$30.40B
MDT annual retained earnings is $30.40 billion

Working capital

$11.15B
MDT annual working capital is $11.15 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$6.79B
MDT annual cash flow from operations is $6.79 billion

Cash from operations 1-year change

+12.39%
MDT annual cash flow from operations is up +12.39% year-on-year

Cash from investing

-$2.37B
MDT annual cash flow from investing activities is -$2.37 billion

Cash from investing 1-year change

+32.26%
MDT annual cash flow from investing activities is up +32.26% year-on-year

Cash from financing

-$4.45B
MDT annual cash flow from financing activities is -$4.45 billion

Cash from financing 1-year change

+10.28%
MDT annual cash flow from financing activities is up +10.28% year-on-year

CAPEX

CAPEX

$1.59B
MDT annual capital expenditures is $1.59 billion

CAPEX 1-year change

+8.77%
MDT annual capital expenditures is up +8.77% year-on-year

Free Cash Flow

Free cash flow

$5.20B
MDT annual free cash flow is $5.20 billion

Free cash flow 1-year change

+13.54%
MDT annual free cash flow is up +13.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

65.34%
MDT annual gross profit margin is 65.34%

Operating margin

17.06%
MDT annual operating profit margin is 17.06%

Net margin

11.36%
MDT annual net profit margin is 11.36%

ROA & ROE

ROA

4.06%
MDT annual return on assets is 4.06%

ROE

7.20%
MDT annual return on equity is 7.20%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

25.21
MDT price to earnings ratio is 25.21

PE ratio Sector rank

53.43%
MDT price to earnings ratio is higher than 53.43% of companies in Healthcare sector

PB Ratio

PB ratio

2.15
MDT price to book ratio is 2.15

PB ratio Sector rank

65.95%
MDT price to book ratio is higher than 65.95% of companies in Healthcare sector

PS Ratio

PS ratio

3.20
MDT price to sales ratio is 3.20

PS ratio Sector rank

55.38%
MDT price to sales ratio is higher than 55.38% of companies in Healthcare sector

Enterprise value

Enterprise value

$131.73B
MDT enterprise value is $131.73 billion

Enterprise value Sector rank

98.43%
MDT enterprise value is higher than 98.43% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

15.22
MDT EV/EBITDA is 15.22

EV/EBITDA Sector rank

88.19%
MDT EV/EBITDA is higher than 88.19% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.03
MDT annual current ratio is 2.03

Quick ratio

1.55
MDT annual quick ratio is 1.55

Leverage

Debt to equity

0.50
MDT annual debt to equity ratio is 0.50

Interest coverage ratio

7.73
MDT annual interest coverage ratio is 7.73

Risk & Stability

Piotroski F-Score

8
MDT piotroski f-score is 8

Altman Z-Score

2.80
MDT altman z-score is 2.80

Analyst ratings

Recent major analysts updates

Mar 4, 25 Citigroup
Buy
Feb 19, 25 UBS
Neutral
Feb 19, 25 RBC Capital
Outperform
Feb 19, 25 Needham
Hold
Feb 19, 25 Baird
Neutral
Feb 12, 25 Needham
Hold
Dec 18, 24 Truist Securities
Hold
Nov 26, 24 Barclays
Overweight
Nov 20, 24 Wells Fargo
Overweight
Nov 20, 24 Needham
Hold

Institutional Ownership

Similar stocks

BMY logo
Bristol-Myers Squibb (BMY)
ELV logo
Elevance Health (ELV)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
PFE logo
Pfizer (PFE)
SNY logo
Sanofi (SNY)
CVS logo
CVS Health (CVS)
GILD logo
Gilead Sciences (GILD)
CI logo
Cigna (CI)
MCK logo
McKesson (MCK)
  • What is the ticker symbol for Medtronic?
  • Does Medtronic pay dividends?
  • What sector is Medtronic in?
  • What industry is Medtronic in?
  • What country is Medtronic based in?
  • When did Medtronic go public?
  • Is Medtronic in the S&P 500?
  • Is Medtronic in the NASDAQ 100?
  • Is Medtronic in the Dow Jones?
  • When was Medtronic's last earnings report?
  • When does Medtronic report earnings?
  • Should I buy Medtronic stock now?

What is the ticker symbol for Medtronic?

The ticker symbol for Medtronic is NYSE:MDT

Does Medtronic pay dividends?

Yes, Medtronic pays dividends. The last payment was $0.70, with an ex-dividend date on March 28, 2025

What sector is Medtronic in?

Medtronic is in the Healthcare sector

What industry is Medtronic in?

Medtronic is in the Medical Devices industry

What country is Medtronic based in?

Medtronic is headquartered in Ireland

When did Medtronic go public?

Medtronic's initial public offering (IPO) was on May 2, 1973

Is Medtronic in the S&P 500?

Yes, Medtronic is included in the S&P 500 index

Is Medtronic in the NASDAQ 100?

No, Medtronic is not included in the NASDAQ 100 index

Is Medtronic in the Dow Jones?

No, Medtronic is not included in the Dow Jones index

When was Medtronic's last earnings report?

Medtronic's most recent earnings report was on Feb 18, 2025

When does Medtronic report earnings?

The next expected earnings date for Medtronic is May 21, 2025

Should I buy Medtronic stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page